Difference between revisions of "Heart transplant pathology"
Jump to navigation
Jump to search
m (→Rejection: tweak) |
m (→IHC: w) |
||
Line 139: | Line 139: | ||
===IHC=== | ===IHC=== | ||
Features:<ref name=pmid17683180>{{cite journal |author=Tan CD, Baldwin WM, Rodriguez ER |title=Update on cardiac transplantation pathology |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1169–91 |year=2007 |month=August |pmid=17683180 |doi= |url=}}</ref> | Features:<ref name=pmid17683180>{{cite journal |author=Tan CD, Baldwin WM, Rodriguez ER |title=Update on cardiac transplantation pathology |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1169–91 |year=2007 |month=August |pmid=17683180 |doi= |url=}}</ref> | ||
*C4d. | *[[C4d]]. | ||
*C3d. | *C3d. | ||
Latest revision as of 18:28, 22 November 2011
Heart transplant pathology is a niche in cardiac pathology.
Overview - table
Types of rejection[1]
Type (grade) | Description | Details | Image |
antibody-mediated rejection (acute vascular) | edema, dilated small vessels | scant inflammation | acute |
normal (0R) | normal | no extravascular monocytes | |
acute cellular (1R) | (perivascular) inflammatory infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmacytic), scant damage | mild cellular |
acute cellular (2R) | (perivascular) inflammatory space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmacytic), obvious damage (myocyte eosinophilia or drop-out) | mod. cellular, mod. cellular resolving |
acute cellular (3R) | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss/damage | |
chronic | concentric intimal thicking | internal elastic lamina preserved (unlike atherosclerosis) | chronic, chronic |
Pitfalls[1]
Name | Description | Details | Image |
Quilty effect | endocardial/subendocardial B-lymphocytes (in clusters) | may extend into myocardium, not assoc. with blood vessels +/-myocyte damage; benign behaviour clinically | Quilty effect, Quilty effect |
Old biopsy site | hemosiderin-laden macrophages | fibrosis/myocyte replacement | old Bx site |
Mimics
Biopsy site reaction
General
- Can be confused for rejection.
Microscopic
Features:
- Hemosiderin-laden macrophages.
- +/-Fibrosis/myofibre loss-replacement.
- +/-Scant inflammatory infiltration.
Image: Biopsy site (pathconsultddx.com).
Quilty effect
General
- Can be confused for rejection.
- Benign behaviour.
Trivia:
- The name Quilty comes from the patient in which this was first recognized.
Microscopic
Features:[3]
- Lymphocytes in clusters (B cells and T cells).
- Associated with the endocardium ("endothelium of the heart"), i.e. on the surface - key feature.
- Often have capillaries in centre; usu. not associated with large blood vessels.
- Lymphocytes separated by collagen.
Notes:
- No longer subclassified.[2]
- Traditional classification (by location):
- Quilty A: Endocardial/subendocardial.
- Quilty B: Endocardial/subendocardial + myocardium.
- +/-Myocyte damage.[4]
- Traditional classification (by location):
Images:
IHC
Mix of T cell and B cells:[3]
- CD3 +ve.
- CD20 +ve.
Notes:
- ACR is T cells.[3]
Coronary atherosclerosis (ischemic injury)
General
- Usu. early - related to atherosclerosis in the donor heart.
- Not typically biopsied. (???)
Microscopic
Features:
- Findings seen in atherosclerosis.
Rejection
It comes in different flavours:[5]
- Antibody-mediated rejection (acute vascular rejection).
- Acute cellular rejection.
- Chronic rejection.
Antibody-mediated rejection
- Abbreviated as AMR.
General
Microscopic
Features:[7]
- Edema.
- Dilated small vessels.
- Scant inflammatory infiltrate.
- Macrophage margination.[8] (???)
Image:
IHC
Features:[2]
- C4d.
- C3d.
Acute cellular rejection
General
- Common form of rejection.
Microscopic
Features:
- Perivascular lymphocytic infiltrate, usu. deep.
- Reactive endothelium.
- +/-Myocardial eosinophilia.
- +/-Expansion of perivascular space.
Notes:
- The main DDx is a Quilty lesion - these are attached to the surface and are typically not associated with a blood vessel.
Grading - comparison
Grading scheme 2004/1990:[9]
Grade 2004 | Grade 1990 | Description | Details | Image |
0R | 0 | normal | no extravascular monocytes | |
1R | 1A | infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmic), scant damage | mild |
1R | 1B | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), focal damage | |
1R | 2 | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), obvious damage | |
2R | 3A | space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmic), obvious damage | mod., mod. resolving |
3R | 3B | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), obvious damage | |
3R | 4 | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss |
Chronic rejection
General
- AKA transplant arteriopathy or cardiac allograft vasculopathy.
- Thought to be a form of accelerated atherosclerosis.[10]
Microscopic
Features:[11]
- Concentric intimal thickening.
- Preservation of internal elastic lamina.
Images:
Notes:
- Morphologically vaguely similar to atherosclerosis.
Other
Post-transplant lymphoproliferative disorder
Main article: Post-transplant lymphoproliferative disorder
- Abbreviated PTLD.
General
Microscopic
Features:
- Large cell lymphoma - see DLBCL.
See also
References
- ↑ 1.0 1.1 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136-7. ISBN 978-0781765275.
- ↑ 2.0 2.1 2.2 2.3 Tan CD, Baldwin WM, Rodriguez ER (August 2007). "Update on cardiac transplantation pathology". Arch. Pathol. Lab. Med. 131 (8): 1169–91. PMID 17683180.
- ↑ 3.0 3.1 3.2 URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 8 March 2011.
- ↑ Winters GL (March 1997). "The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection". Curr. Opin. Cardiol. 12 (2): 146–52. PMID 9192483.
- ↑ URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 9 Febraury 2011.
- ↑ Olsen SL, Wagoner LE, Hammond EH, et al. (1993). "Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations". J. Heart Lung Transplant. 12 (2): S135–42. PMID 8476883.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4. Accessed on: 7 January 2011.
- ↑ Lee CY, Lotfi-Emran S, Erdinc M, et al. (November 2007). "The involvement of FcR mechanisms in antibody-mediated rejection". Transplantation 84 (10): 1324–34. doi:10.1097/01.tp.0000287457.54761.53. PMID 18049118.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136. ISBN 978-0781765275.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 137. ISBN 978-0781765275.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5. Accessed on: 7 January 2011.
- ↑ URL: http://newsroom.ucla.edu/portal/ucla/ucla-team-uncovers-mechanism-behind-179330.aspx. Accessed on: 7 January 2011.
- ↑ URL: http://emedicine.medscape.com/article/431364-overview. Accessed on: 10 February 2011.